1. What Is the Supercritical Fluid Chromatography Market?
The Supercritical Fluid Chromatography Market encompasses analytical and preparative chromatography systems, columns, and consumables that use supercritical or subcritical carbon dioxide as the primary mobile phase component. This achieves faster separations with reduced organic solvent consumption compared with conventional liquid chromatography. The market includes analytical SFC systems for chiral compound analysis and pharmaceutical impurity profiling and preparative SFC systems for chiral enantiomeric separation and compound purification. It also includes SFC columns with diverse stationary phases including chiral polysaccharide, C18, and specialty bonded silica phases. These systems are operated by pharmaceutical analytical chemists, chiral method development scientists, and pharmaceutical process chemists to perform rapid chiral purity analysis, green compound purification, and achiral normal phase separation without toxic hexane-based mobile phases. Market scope covers SFC analytical and preparative instruments, SFC-specific column formats, and CO2 delivery and back-pressure regulator accessories for supercritical fluid chromatographic applications. It excludes supercritical fluid extraction systems, gas chromatography, and conventional HPLC systems not using CO2 mobile phases.
2. Supercritical Fluid Chromatography Market Size & Forecast
3. Emerging Technologies
- Lipid and natural product SFC analysis is advancing comprehensive SFC methods for fatty acid, triglyceride, phospholipid, and sterol analysis that provide faster separation and improved resolution over conventional reversed phase HPLC lipid methods without. Growing industry adoption of this technology is motivating development.
- High-throughput SFC screening for drug discovery is advancing automated SFC sample preparation and injection platforms that enable screening of hundreds of synthesised compounds per day for chiral purity, impurity profile. Growing industry adoption of this technology is motivating development.
- Unified chromatography platform technology is advancing single systems capable of operating as both SFC and UHPLC from the same instrument with rapid mobile phase switching, enabling laboratories to perform both SFC and HPLC. Growing.
- Column selectivity library expansion for SFC is advancing development of novel bonded stationary phases with improved SFC compatibility including fluorous, ionic liquid, and mixed mode SFC columns that provide orthogonal selectivity to conventional. Growing.
Similar technologies are also transforming adjacent markets. Learn more in our Ion Chromatography Market.
4. Key Market Opportunity
A key opportunity in the Supercritical Fluid Chromatography Market is the expansion of SFC adoption in pharmaceutical impurity profiling as analytical chemists recognise SFC's orthogonal selectivity to HPLC provides complementary impurity resolution beyond what any single HPLC method achieves. A significant proportion of pharmaceutical analytical scientists developing ICH Q3A and Q3B impurity profiling methods use only HPLC-based methods, missing the additional impurity resolution achievable from SFC's different selectivity that detects impurities not resolved by HPLC. Regulatory guidance encouraging orthogonal analytical methods for impurity profiling creates an opportunity for SFC adoption as the complementary orthogonal technique to HPLC providing independent selectivity-based impurity detection. SFC instrument manufacturers that provide validated SFC-HPLC orthogonal impurity profiling method packages, generate pharmacopoeia-compliant SFC impurity method examples, and demonstrate SFC specificity advantages for common pharmaceutical impurity classes are positioned to grow SFC adoption.
5. Top Companies in the Supercritical Fluid Chromatography Market
The following organisations hold leading positions in the Supercritical Fluid Chromatography Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Waters Corporation (UPC2)
- Agilent Technologies
- Shimadzu
- JASCO
- Thar Technologies (Waters)
- Regis Technologies
- Daicel Chemical
- Princeton Chromatography
- Tosoh Bioscience
- Lux Analytix
6. Market Segmentation
The Supercritical Fluid Chromatography Market is analysed across 5 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By System Type | Analytical SFC Chiral Analytical SFC Achiral Environmental SFC Preparative SFC Semi-Preparative 10-50ml/min Large-Scale Prep SFC Above 100ml/min Unified Chromatography SFC-MS Process SFC |
| By Column Type | Chiral Polysaccharide Column Immobilised Polysaccharide Column Coated Polysaccharide Column C18 SFC Column Polar Embedded SFC Specialty SFC Column Achiral Normal Phase SFC |
| By Application | Chiral Method Development Pharmaceutical Impurity Analysis Natural Product Analysis Food Lipid Analysis Drug Discovery Screening Environmental Analysis |
| By End User | Pharmaceutical Manufacturers CDMOs Contract Research Organisations Food Companies Academic Research |
| By Geography | North America The U.S. Canada Europe The UK Germany France Italy Spain Denmark Netherlands Finland Sweden Norway Russia Austria Poland Rest of Europe Asia Pacific China Japan India South Korea Australia Indonesia Vietnam Philippines Singapore Taiwan Thailand Rest of Asia Pacific Latin America Brazil Mexico Argentina Rest of South America Middle East and Africa GCC Countries Israel South Africa Rest of Middle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Supercritical Fluid Chromatography Market trajectory over the forecast period:
Waters Ultra Performance SFC Technology Is Enabling the Fastest Chiral Analytical Screening in Pharmaceutical Chiral Method Development.Pharmaceutical analytical chemists performing chiral purity analysis method development for new drug candidates are adopting Waters UPC2 ultra performance SFC as the fastest chiral screening system as sub-2-micron particle SFC columns. High-pressure CO2 delivery enable 3 to 5 minute analytical chiral separations versus 15 to 30 minute conventional analytical HPLC chiral methods. Waters Corporation continued commercial development of the Arc UPC2 and SFC System ultra performance chromatography platforms in 2024, maintaining market leadership in analytical SFC with updated system reliability improvements and expanded chiral. Achiral column portfolios validated for SFC conditions.
Preparative SFC Chiral Technology Is Replacing Hexane-Based Normal Phase HPLC for Pharmaceutical Chiral Enantiomeric Purification at Scale.Pharmaceutical CDMOs and pharmaceutical process chemists performing chiral enantiomeric separation of racemic APIs at preparative scale are converting from hexane-isopropanol normal phase chiral HPLC to preparative SFC. CO2-based chiral SFC demonstrates 3 to 5 times higher throughput and 80 to 90 percent lower organic solvent consumption at equivalent enantiopurity. Waters Corporation and Agilent Technologies continued commercial development of preparative SFC systems for pharmaceutical chiral API purification in 2024. This grows cDMO and pharmaceutical manufacturer conversion from normal phase chiral HPLC as preparative SFC method transfer protocols mature.
SFC-MS Coupling Technology Is Enabling Chiral Purity Analysis with Structural Confirmation in a Single Analytical Run.Pharmaceutical analytical scientists performing impurity profiling and chiral purity analysis are adopting SFC-MS coupled systems that provide simultaneous SFC separation and mass spectrometry structural identification. This enables impurity characterisation and chiral purity confirmation from a single SFC-MS injection. Waters Corporation and Agilent Technologies continued development of SFC-MS coupling interfaces and validated SFC-MS methods for pharmaceutical impurity profiling in 2024. This provides analytical scientists with integrated SFC separation and mass spectrometric identification from a single analytical run.
For related market intelligence, see the Gas Chromatography Market.
8. Segmental Analysis
By system type, analytical SFC dominated the Supercritical Fluid Chromatography Market in 2025, driven by pharmaceutical chiral method development adoption of ultra-high-performance SFC as the fastest analytical chiral screening and purity analysis platform. Pharmaceutical analytical chemists continue specifying analytical SFC as the primary chiral purity analysis platform as Waters UPC2 and similar systems achieve 3 to 5 minute chiral separations enabling high-throughput compound screening and purity monitoring. Preparative SFC systems are the fastest-growing system type, driven by growing pharmaceutical CDMO and manufacturer conversion from hexane-based normal phase chiral HPLC to preparative SFC for higher-throughput and lower-solvent chiral enantiomeric purification. Pharmaceutical CDMOs and process chemists are increasing preparative SFC adoption as validated chiral SFC method transfer protocols mature and productivity comparisons demonstrate compelling throughput and solvent reduction advantages.
By application, chiral method development dominated the Supercritical Fluid Chromatography Market in 2025, driven by the primary application of analytical SFC as the pharmaceutical industry standard for rapid chiral purity analysis and enantiomeric ratio determination. Pharmaceutical analytical scientists continue generating the highest SFC demand in chiral method development as analytical SFC column screening platforms provide the fastest approach to identifying optimal chiral stationary phase and mobile phase conditions. Pharmaceutical impurity analysis is the fastest-growing application, driven by increasing pharmaceutical analytical recognition of SFC's orthogonal selectivity to HPLC for detecting impurities not resolved by standard HPLC methods in impurity profiling. Pharmaceutical analytical chemists are increasing SFC impurity profiling adoption as orthogonal selectivity to HPLC provides independent impurity detection capability that regulatory guidance for comprehensive impurity profiling increasingly endorses.
9. Regional Analysis
Regional demand patterns across the Supercritical Fluid Chromatography Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America accounted for the largest share of the Supercritical Fluid Chromatography Market in 2025, holding 45.0% of the global market. The region's dominance reflects the large United States pharmaceutical analytical development community driving SFC adoption for chiral purity analysis and green impurity profiling, the headquarters of Waters Corporation as the leading SFC instrument manufacturer, and the established pharmaceutical and CDMO chiral development infrastructure in North America. The large United States pharmaceutical analytical development community at major pharmaceutical companies and CDMOs generates consistent SFC system and column demand as chiral purity method development and preparative SFC adoption grow from early-adopter programmes to mainstream analytical practice. Growing United States pharmaceutical industry green chemistry commitment to reducing hexane-based normal phase HPLC is accelerating SFC adoption as the CO2-based alternative that achieves equivalent normal phase separation performance with substantially reduced organic solvent waste.
Highest CAGR Region
Asia Pacific is expected to register the highest CAGR of 16.80% during the forecast period. Growing pharmaceutical analytical laboratory investment in SFC capability in Japan, South Korea, and China, expanding CDMO chiral SFC service capacity in China and India, and increasing food lipid research interest in SFC as an alternative to conventional HPLC lipid analysis across the region are creating SFC market growth. Growing Japanese and South Korean pharmaceutical company analytical department adoption of SFC as the preferred chiral analytical method and preparative platform is creating consistent SFC system and chiral column demand at Asia Pacific pharmaceutical analytical development laboratories. Growing Chinese CDMO sector chiral separation service capability investment in preparative SFC is creating demand for preparative SFC systems as Chinese CDMOs expand their chiral purification service offerings for international pharmaceutical client programmes.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology Adoption Trends and Innovation Tracking
- • Custom Company Profiling and Benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country-Level Opportunity Mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Supercritical Fluid Chromatography Market was valued at USD 562.80 Mn in 2025 and is projected to reach USD 1,560.69 Mn by 2034, growing at a CAGR of 12.00% over the 2026–2034 forecast period.
The Supercritical Fluid Chromatography Market is projected to grow at a CAGR of 12.00% from 2026 to 2034.
North America accounted for the largest share of the Supercritical Fluid Chromatography Market in 2025, holding 45.0% of the global market.
The leading companies in the Supercritical Fluid Chromatography Market include Waters Corporation (UPC2), Agilent Technologies, Shimadzu, JASCO, Thar Technologies (Waters), Regis Technologies, Daicel Chemical, Princeton Chromatography, Tosoh Bioscience, Lux Analytix.
Waters ultra performance sfc technology is enabling the fastest chiral analytical screening in pharmaceutical chiral method development.
By system type, analytical SFC dominated the Supercritical Fluid Chromatography Market in 2025, driven by pharmaceutical chiral method development adoption of ultra-high-performance SFC as the fastest analytical chiral screening and purity analysis platform.
How to Order
Choose Your Package
Condensed edition of this study for students, researchers and academic institutions.
- Condensed edition of the full study
- For students, researchers & academic institutions
- Valid student ID or institutional email required
- Educational, non-commercial use only
The competitive landscape, including key market participants, company size, market positioning, and comparative competitive standing.
- 15 in-depth company profiles
- Company overview
- Product and brand portfolio mapped per company
- Revenue for the last 3 FYs with key financial metrics
- Segmental revenue and regional revenue breakdown
- Market presence, key geographies & end-use industries
- Recent developments
- Key capabilities, differentiators & strategic positioning
- SWOT Analysis
- 15-company market share analysis
- 2025 market share by company
- Company revenue in USD
- Competitive quadrant positioning
- Product portfolio comparison
The complete forecast model, including every study table, is provided in clean, formula-ready Excel format across 4 segmentation axes. Select the geographic coverage required for your analysis.
- One country, broken out across 4 segmentation axes
- 2025 base year, 2026–2034 forecast, CAGR per line
- Excel workbook
- Region totals plus every country inside that region
- All axes, all years, CAGR per line
- Cross-country comparison sheet included
- Excel workbook
- Every forecast table in the study
- Global, regional and country views in one workbook
- Segment share and CAGR pivots included
- Excel workbook
The full syndicated study. Every chapter, every region, every country, plus the complete Excel model, methodology and appendix.
- Executive summary, market scope & segmental snapshot
- Market dynamics: drivers, restraints, opportunities, challenges
- Quantitative analysis across 4 segmentation axes
- Regional analysis
- Competitive landscape, market share & company revenue mapping
- Includes the full Global Excel Data Pack
- Complete research methodology, assumptions & appendix
TAM/SAM/SOM sizing, M&A target screening, patent & IP analysis, supply-chain resilience mapping, ESG roadmaps and other bespoke strategic work.
- TAM / SAM / SOM sizing
- M&A target screening
- Patent & IP analysis
- Supply-chain resilience mapping
- ESG roadmaps & other bespoke strategic work
Not sure which package fits? Tell us the decision you are making and an analyst will recommend the smallest package that answers it. Talk to an analyst.
Ordering Process
Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.